Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 30 May 24 424B5 Prospectus supplement for primary offering
- 13 Nov 23 424B5 Prospectus supplement for primary offering
- 15 Sep 23 424B5 Prospectus supplement for primary offering
- 18 Aug 23 424B5 Prospectus supplement for primary offering
- 28 Jun 22 424B5 Prospectus supplement for primary offering
- 23 Jun 22 424B5 Prospectus supplement for primary offering
- 17 May 22 424B5 Prospectus supplement for primary offering
- 22 Mar 22 424B5 Prospectus supplement for primary offering
- 6 Jul 21 424B5 Prospectus supplement for primary offering
- 1 Jul 21 424B5 Prospectus supplement for primary offering
- 13 Jan 21 EFFECT Notice of effectiveness
-
31 Dec 20 S-3 Shelf registration
BSGM similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 13, 2020, relating to the consolidated financial statements of BioSig Technologies, Inc. (the “Company”), appearing in the Annual Report on Form 10-K of the Company for the year ended December 31, 2019, and to the reference to us under the heading "Experts" in the Prospectus, which is part of this Registration Statement.
/s/ Liggett & Webb, P.A.
New York, New York
December 31, 2020